APA (7th ed.) Citation

YW, S., YH, P., YM, H., FJ, T., R, C., & SS, K. (2026). New oral anticoagulants and hepatocellular carcinoma among patients with HBV, HCV, and alcoholic liver diseases: A nationwide cohort study. Hepatology international. https://doi.org/10.1007/s12072-026-11117-0

Chicago Style (17th ed.) Citation

YW, Su, Pai YH, Hung YM, Tsai FJ, Chang R, and Kao SS. "New Oral Anticoagulants and Hepatocellular Carcinoma Among Patients with HBV, HCV, and Alcoholic Liver Diseases: A Nationwide Cohort Study." Hepatology International 2026. https://doi.org/10.1007/s12072-026-11117-0.

MLA (9th ed.) Citation

YW, Su, et al. "New Oral Anticoagulants and Hepatocellular Carcinoma Among Patients with HBV, HCV, and Alcoholic Liver Diseases: A Nationwide Cohort Study." Hepatology International, 2026, https://doi.org/10.1007/s12072-026-11117-0.